Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00484432
Status:
COMPLETED
Last Update Posted:
2018-09-27
First Post:
2007-06-07
Brief Title:
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer
Sponsor:
AGC Biologics SpA
Organization:
AGC Biologics SpA
Organization Data
Organization:
AGC Biologics SpA
Class:
INDUSTRY
Study ID:
NGR012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AGC Biologics SpA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None